Abstract
The design of an effective procedure to sensitize and expand antigen- specific cytotoxic T lymphocytes (CTL) in vitro is essential for the development of effective adoptive cellular immunotherapy protocols for cancer. We have analyzed the capacity of tissue culture-derived dendritic cells (DC) to present specific peptide epitopes to CTL precursors. Our results demonstrate that peptide-pulsed DC were efficient in generating CTL responses specific for various vital and tumor epitopes. Furthermore, IL-7 and IL-10 potentiated the ability of the peptide-pulsed DC to trigger antigen-specific CTL responses. The CTL generated using this procedure efficiently recognized the naturally processed antigens and could be expanded approximately 100- to 1000-fold in tissue culture in 10 to 15 days without a loss of activity and specificity. The results and procedures described herein may facilitate the development of effective CTL-based adoptive immunotherapy for chronic vital diseases and cancer.
Original language | English (US) |
---|---|
Pages (from-to) | 65-75 |
Number of pages | 11 |
Journal | Critical Reviews in Immunology |
Volume | 18 |
Issue number | 1-2 |
State | Published - Jan 1 1997 |
Externally published | Yes |
Keywords
- CTL
- Dendritic cells
- MHC binding peptides
- Tumor antigens
ASJC Scopus subject areas
- Immunology and Allergy
- Immunology